VolitionRx Limited, a multinational epigenetics company, has announced its participation in the official launch of the DETECSEPS Consortium in France. This government-funded project focuses on the early detection of sepsis, a critical and life-threatening condition. The initiative aligns with VolitionRx's mission to improve diagnosis and monitoring of serious diseases. This collaboration could lead to significant advancements in sepsis detection and patient outcomes.
VolitionRx's DETECSEPS program launch in France is presented here with Pluang's Health-sector market data as of Sep 17, 2026 19:42 WIB. Among 91 priced Health-sector US stocks tradable on Pluang, 74 rose and 15 fell today. Notable movers include ABCL at USD 12.07 with a 1-day change of +3.43% and Pluang order activity heavily skewed to 99% Sell, ASND at USD 239.50 down 3.31% with 91% Sell activity, and SANA at USD 3.01 up 3.08% with 86% Sell activity. The typical hold time on Pluang ranges from 22 to 55 days for these stocks.
Fluence Energy's stock price target was cut sharply from $15.00 to $4.00 by RBC Capital analyst Christopher Dendrinos after the company slashed its 2026 revenue forecast from $3.00 billion to $2.40 billion. The company now expects an adjusted EBITDA ...
Regency Centers reported solid Q2 2026 results with Funds From Operations (FFO) at $1.21 per share and a 3.8% growth in same-property Net Operating Income (NOI). The company raised its full-year guidance, signaling confidence in continued growth. Reg...
Ciena reported a 37% revenue increase to $1.67 billion and a 215% rise in adjusted EPS to $2.11 in its fiscal third quarter, driven by strong demand from AI and cloud infrastructure. The company is well positioned to benefit from the AI networking ma...
Maureen Gellerman, Chief Human Resources Officer at Five Below, sold 1,610 shares of the company, generating $401,000 from the transaction. This insider sale may indicate personal financial planning or portfolio rebalancing but does not necessarily r...
ON Semiconductor is focusing on advanced power-density technologies for AI data centers and electric vehicles, aiming for $2.5 billion revenue from AI alone by 2030. Despite a Neutral rating from UBS, the company introduced its Embedded Power Platfor...
